May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first implantation of its bioprosthetic artificial heart in Denmark.
Cardiovascular Surgery
This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.
-
-
May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal...
-
April 7, 2020 — The U.S.
-
March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when surgeons used a segment of the radial artery from their arm, instead a saphenous...
News | Artificial Heart | May 27, 2020
May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first...
The Breethe ECMO system. Abiomed invested in Breethe in mid-2019. Breethe has applied for 510(k) clearance by the Food and Drug Administration (FDA).
News | ECMO Systems | May 01, 2020
May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal...
The FDA expanded the use indications for ECMO systems April 6 so the systems can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support. Image shows an ECMO team at work at Tufts Medical Center in Boston in December 2019. Photo by Dave Fornell
News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand...
An ECMO cannula being inserted into a cardiovascular patient in need of mechanical oxygenation and hemodynamic support at Tufts Medical Center in December 2019. The FDA just made a temporary approval to use ECMO support in COVID-19 patients during the pandemic emergency. Photo by Dave Fornell.
Feature | Coronavirus (COVID-19) | April 07, 2020 | Dave Fornell, Editor
April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the...
Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images.
News | Cardiovascular Surgery | March 30, 2020
March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when...
Conclusions from the real world TAVR vs. surgery trial for aortic valve replacement outcomes in the U.K., presented by William D. Toff, M.D. at ACC 20.
News | Heart Valve Technology | March 30, 2020
March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did...
Feature | Heart Valve Technology | March 30, 2020
March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well...
News | Heart Valve Technology | March 29, 2020
March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing...
Feature | Heart Valve Technology | March 29, 2020 | Dave Fornell, Editor
March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve...
Feature | Coronavirus (COVID-19) | March 20, 2020 | Dave Fornell, Editor
March 20, 2020 — The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective...
Videos | Coronavirus (COVID-19) | March 20, 2020
An interview with Ehtisham Mahmud, M.D., FSCAI, chief, Division of Cardiovascular Medicine, executive director of...
News | Artificial Heart | March 10, 2020
March 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total...
The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate.
Feature | Coronavirus (COVID-19) | March 09, 2020
March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel...
News | Heart Failure | March 05, 2020
March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (...
The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.
News | Cardiovascular Surgery | February 27, 2020
February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to...
